| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/16/2004 | EP1427836A2 Pseudotyped retroviral vector system |
| 06/16/2004 | EP1427827A2 Synthetic hcv envelope proteins and their use for vaccination |
| 06/16/2004 | EP1427814A1 Pancreatic small cells and uses thereof |
| 06/16/2004 | EP1427813A2 Method for dendritic cells-based immunotherapy of tumors using combination therapy |
| 06/16/2004 | EP1427811A1 Erythrocytic cells and method for preserving cells |
| 06/16/2004 | EP1427808A1 Lactic acid producing bacteria for use as probiotic organisms in the human vagina |
| 06/16/2004 | EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 06/16/2004 | EP1427462A1 Method for inducing selectively suppressed immune response |
| 06/16/2004 | EP1427445A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules |
| 06/16/2004 | EP1427436A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 06/16/2004 | EP1326622A4 Compositions and methods for treatment of multiple myeloma |
| 06/16/2004 | EP1171140B1 Treatment of hypersensitivity reaction disorders |
| 06/16/2004 | EP1152767B1 Method for producing anti-tumor th1 cells |
| 06/16/2004 | CN1505678A Lactic acid bacteria as agents for treating and preventing allergy |
| 06/16/2004 | CN1505537A Disease prevention by reactivation of the thymus |
| 06/16/2004 | CN1505526A Compositions and methods for wt1 specific immunotherapy |
| 06/16/2004 | CN1505524A Immunopotentiators |
| 06/16/2004 | CN1505522A Stimulation of thymus for vaccination development |
| 06/16/2004 | CN1504713A Process and apparatus for drying donkey-hide gelatin by microwave |
| 06/16/2004 | CN1504212A Medicine for nourishing yin and fortifying kidney, benefiting qi and fortifying spleen , and its preparation method |
| 06/16/2004 | CN1504201A Medication for nourishing yin and strengthening yang and preparation method |
| 06/16/2004 | CN1504200A Red-legged disease, curlworm disease ecotype, immunity and prevention and cure technique of eelworm |
| 06/16/2004 | CN1504199A Luminescent bio-element and preparation process |
| 06/16/2004 | CN1153583C Medicine for bone injury |
| 06/16/2004 | CN1153580C Traditional Chinese medicine for treating lymph tuberculosis |
| 06/16/2004 | CN1153579C Buccal tablets for activating intelligent genes and increasing intelligence quotient |
| 06/16/2004 | CN1153578C Medicine for treating bone fracture and osteopathy |
| 06/16/2004 | CN1153576C Composition and method for treating bladder cancer |
| 06/16/2004 | CN1153575C Pharmaceutical preparation comprising rhamnose lactobacillus |
| 06/16/2004 | CN1153574C Use of bacterial cell wall extracts for treating, preventing or removing protozoan or parasite diseases |
| 06/16/2004 | CN1153573C Application of bamboo rat's serum and medicine containing said serum |
| 06/16/2004 | CN1153512C Method of using oxygen removal for extending shelf-life of refrigerated red blood cells |
| 06/16/2004 | CN1153510C Vaccination against coccidiosis in ovum |
| 06/16/2004 | CN1153509C Vaccination against coccidiosis in ovum |
| 06/15/2004 | US6750206 Recombinant nucleic acid vector comprising a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 06/15/2004 | US6750043 Expression vector for use in the expression of heterologous protein in cells |
| 06/15/2004 | US6749870 Compositions and methods for the control of smoking |
| 06/15/2004 | US6749850 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 06/15/2004 | CA2086642C Method of treating hyperproliferative vascular disease |
| 06/10/2004 | WO2004048568A1 UTILIZATION OF mKank GENE IN CANTER THERAPY, CANER DETECTION AND DRUG DISCOVERY |
| 06/10/2004 | WO2004047860A2 Cells not presenting antigen for suppressing pathological immune reactions |
| 06/10/2004 | WO2004047856A1 Cancer metastasis inhibitor |
| 06/10/2004 | WO2004047849A1 Clinical application of dendritic cell-based cancer immunotherapy |
| 06/10/2004 | WO2004047770A2 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 06/10/2004 | WO2004047766A2 Treatment for sma disease |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | WO2004047747A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/10/2004 | WO2004047746A2 Regulation of stearoyl-coa desaturase to treat obesity |
| 06/10/2004 | WO2004047620A2 Fixation method for bioprostheses |
| 06/10/2004 | WO2004047566A1 Nutritional compositions |
| 06/10/2004 | WO2004037202A9 Gb virus c and methods of treating viral infections |
| 06/10/2004 | WO2004033672A3 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 06/10/2004 | WO2004024865A3 Biocontrol for plants with bacillus subtilis, pseudomonas putida, and sporobolomyces roseus |
| 06/10/2004 | WO2004013343A3 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 06/10/2004 | WO2004006801A3 Treatment for dry eye syndrome |
| 06/10/2004 | WO2004005488A3 Replacing liver cells with bone marrow-derived cells for treating disease and expressing therapeutic genes |
| 06/10/2004 | WO2004003235A3 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 06/10/2004 | WO2003078567A3 Methods of inducing differentiation in ex vivo expanded stem cells |
| 06/10/2004 | WO2003040170A9 Antibodies to cd40 |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | WO2002038168A3 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 06/10/2004 | US20040110919 Comprises toxic jellyfish protein for use as pesticide |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110709 Genetic modification of the lung as a portal for gene delivery |
| 06/10/2004 | US20040110707 Method of treating neurological diseases |
| 06/10/2004 | US20040110695 Phospholipid vesicle having exogenous antigen orpolynucleic acid coding for antigen; adapted to be phagocytosed by antigen presenting cells |
| 06/10/2004 | US20040110289 Obtaining liver cells suspension via proteolytic digestion followed by density gradient centrifugation; liver regeneration and transplantation therapy |
| 06/10/2004 | US20040110288 Neuronal multipotent cell culture for use in the treatment of nervous system disorders and spinal cord injury; drug screening; tissue engineering; cell transplantation therapy |
| 06/10/2004 | US20040110287 Culturing pancreatic tissue for use in replenishment of functional glucose-sensing, insulin-secreting pancreatic beta cells; pancreatic injury and diabetes treatments |
| 06/10/2004 | US20040110270 Bacterial composition and its use |
| 06/10/2004 | US20040110236 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 06/10/2004 | US20040109903 Method for extended storage of viable and pathogen-safe blood and blood components using carbon monoxide |
| 06/10/2004 | US20040109899 Antiviral medicament and method for producing and using the same for the prophylactic and therapeutic treatment of papillomavirus induced tumors, lesions and deseases |
| 06/10/2004 | US20040109898 Mixture of glycerin as fluid carrier and capsicum plant extract; sexual disorders |
| 06/10/2004 | US20040109880 Cosmetic and/or pharmaceutical preparations |
| 06/10/2004 | US20040109878 Removal cancer, organ transplant and autoimmune cells from bone marrow, blood |
| 06/10/2004 | US20040109877 Rna viruses; attenuation influenza virus |
| 06/10/2004 | US20040109872 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 06/10/2004 | US20040109859 Method for the treatment of multiple sclerosis |
| 06/10/2004 | US20040109851 Use of immature dendritic cells to silence antigen specific cd8cell function |
| 06/10/2004 | CA2854831A1 Treatment of mammalian reaction to ige interactions |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2506683A1 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 06/10/2004 | CA2505534A1 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 06/10/2004 | CA2474066A1 Clinical application of dendritic cell-based cancer immunotherapy |
| 06/09/2004 | EP1426030A1 Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof |
| 06/09/2004 | EP1426028A1 Method of extract composition control in peat extraction, peat extract, and use of peat extract |
| 06/09/2004 | EP1426021A1 Implantable system with drug eluting cells for on-demand local drug delivery |
| 06/09/2004 | EP1425399A2 Combinatorial methods for inducing cancer cell death |
| 06/09/2004 | EP1425390A2 Materials and methods to promote repair of nerve tissue |
| 06/09/2004 | EP1425388A2 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use |
| 06/09/2004 | EP1425381A2 Emu-based formulations for wound treatment related application information |
| 06/09/2004 | EP1425305A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 06/09/2004 | EP1425297A2 Isolation of neural stem cells using gangliosides and other surface markers |
| 06/09/2004 | EP1425047A1 Method for improving oxygen transport by stored red blood cells |
| 06/09/2004 | EP1425046A2 Wild-type ras as a cancer therapeutic agent |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425034A1 Method for treating coumarin-induced hemorrhage |
| 06/09/2004 | EP1424897A2 Compositions and methods for treatment of cancer |